Net Income

AIROS Medical's FDA-cleared ARTAIRA device brings non-invasive PAD therapy home as global cases are projected to surge past 360 million by 2050.

A new study shows shoppers love AI for research, but decision overload persists, forcing retailers to rethink their entire strategy in an AI-driven world.

Amid strong revenue growth, Capstone's focus on powering AI and datacenters takes center stage as investors await crucial Q3 financial results.

With 46% of developers distrusting AI code, Qodo 2.0's new multi-agent architecture aims to restore faith by delivering more accurate, context-aware reviews.

The frozen potato giant appoints an AB InBev veteran as Executive Chair and a new CFO, signaling a major push for global expansion and shareholder value.

Amid OEM delays, a 20-year veteran with a long history with the firm joins Next Level Aviation to steer its procurement strategy and fuel growth.

The AI boom runs on powerful chips that generate immense heat. Discover how the once-overlooked HVAC industry is now a critical infrastructure investment.

With a fresh capital infusion extending its runway into 2027, GRI Bio pushes ahead with promising clinical data for its IPF and autoimmune disease pipeline.

At HIMSS 2026, Hyland unveils agentic automation tools to slash paperwork, streamline workflows, and give clinicians more time for patient care.

A new survey reveals championship fleets operate like elite sports teams, prioritizing safety, real-time data, and recognizing their most valuable players.

Amid financial scrutiny and following a major trial failure, Vistagen's upcoming Q3 update is a critical test for its novel pherine pipeline.

Fold's new app aims to make bitcoin simple for daily use, but can it stand out in a crowded market and deliver on its long-term promises?

The tech platform is rapidly expanding, using private lots to solve a $100B industry problem and aiming for 10,000 locations by the end of 2026.

A Chinese tech firm plans to bring its automated parking solutions to NYC and LA, facing a crowded market, financial hurdles, and geopolitical scrutiny.

With multiple Best in KLAS awards, Bluesight cements its leadership in patient safety and data security. Here's why hospitals trust their solutions.

As GLP-1 drugs dominate, Veru Inc. advances a novel therapy to combat muscle loss, aiming for a new standard of 'quality' weight loss in older adults.

With a top industry award, CodaMetrix validates autonomous AI's power to fix healthcare's costly billing woes, reshaping both finances and jobs.

The 90-year-old insurer goes live with Equisoft's SaaS platform, tackling industry-wide tech debt to boost agent efficiency and speed product launches.

MetaVia's drug vanoglipel gets a major boost from AI modeling, validating its potential to treat complex metabolic diseases like MASH and Type 2 Diabetes.

As AI's power needs skyrocket, GridAI brings in veteran Tim Healy to lead its charge. Can his software-first approach solve the grid's biggest challenge?